To Evaluate Safety & Reactogenicity of GSK Bio's Human Rotavirus (HRV) Vaccine in Filipino Infants at Least 6 Weeks of Age at First Vaccination

Name: To Evaluate Safety & Reactogenicity of GSK Bio's Human Rotavirus (HRV) Vaccine in Filipino Infants at Least 6 Weeks of Age at First Vaccination
License: Public Domain

GlaxoSmithKline

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

infections, rotavirus, rotavirus vaccines

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 435784
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.